4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-059051
Director acquired 7,176 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kariv Tomer Director | 2022-11-29 | Option exercise | −3,539 | $0.00 | $0 | 2,284,612 | I: show line 1 in the form |
| Kariv Tomer Director | 2022-11-29 | Option exercise | −1,723 | $0.00 | $0 | 1,121,045 | I: show line 2 in the form |
| Kariv Tomer Director | 2022-11-29 | Option exercise | −1,914 | $0.00 | $0 | 1,226,412 | I: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kariv Tomer Director | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −3,539 | 0 | I: show line 4 in the form | |||||
| Kariv Tomer Director | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −1,723 | 0 | I: show line 5 in the form | |||||
| Kariv Tomer Director | 2022-11-29 | Option exercise · Call Options (obligation to sell) | −1,914 | 0 | I: show line 6 in the form |
Loading xslF345X03/doc4.xml…